Aya EL-Taibany | Medicine | Best Researcher Award

Best Researcher Award

Aya EL-Taibany

Wake Forest Institute for Regenerative Medicine

               Aya EL-Taibany
Affiliation Wake Forest Institute for Regenerative Medicine
Country United States
Scopus ID 57217169106
Documents 4
Citations 117
h-index 4
Subject Area Medicine
Event International Research Hypothesis Excellence Award

Aya EL-Taibany is affiliated with the Wake Forest Institute for Regenerative Medicine in the United States and has contributed to scholarly research in the field of medicine, particularly in areas associated with regenerative medicine and translational biomedical science. The available bibliometric indicators, including a Scopus profile comprising four indexed publications and more than one hundred citations, demonstrate a focused research trajectory and measurable scientific influence within a specialized domain.[1]

Abstract

This academic profile summarizes the research activities and scholarly contributions of Aya EL-Taibany, a researcher associated with the Wake Forest Institute for Regenerative Medicine. Bibliometric evidence indicates meaningful contributions within medical and regenerative sciences through peer-reviewed publications and measurable citation performance. The profile further evaluates the relevance of these contributions in relation to the criteria commonly associated with scientific excellence awards and recognition programs.[1]

Keywords

Aya EL-Taibany; Regenerative Medicine; Translational Medicine; Biomedical Research; Scientific Publications; Citation Analysis; Medical Sciences; Research Excellence; Best Researcher Award.

Introduction

Regenerative medicine represents one of the most rapidly evolving areas of contemporary biomedical research, integrating principles from biology, engineering, and clinical sciences to develop innovative therapeutic approaches. Researchers working in this domain contribute to advancing knowledge related to tissue regeneration, disease mechanisms, and translational applications. The academic profile of Aya EL-Taibany reflects engagement with these interdisciplinary scientific themes and demonstrates participation in research activities that support the progression of modern medicine.[3]

Research Profile

Aya EL-Taibany is affiliated with the Wake Forest Institute for Regenerative Medicine in the United States and maintains a documented publication record indexed within major scientific databases. Available bibliometric indicators identify four indexed documents, 117 citations, and an h-index of four, suggesting that the published works have achieved scholarly visibility and influence within relevant research communities.[1]

Research Contributions

The available scientific record indicates contributions to medical and regenerative research through publications addressing translational science and biomedical innovation. Such studies contribute to the understanding of biological processes and support the development of therapeutic strategies designed to improve patient outcomes and expand scientific knowledge.[2]

Publications

The publication portfolio indexed under the author’s Scopus profile demonstrates focused scholarly productivity and reflects contributions to peer-reviewed medical research. Indexed documents have accumulated a significant number of citations relative to the size of the publication record, indicating the relevance and visibility of the published studies within their research fields.[1]

Research Impact

Citation metrics serve as an important indicator of the dissemination and influence of scientific research. The citation profile associated with Aya EL-Taibany demonstrates that the published works have attracted sustained scholarly attention and have contributed to ongoing academic discussions within medicine and regenerative sciences. The relationship between publication quality and citation impact further supports the recognition of these contributions within the broader scientific community.[4]

Award Suitability

The criteria commonly associated with the International Research Hypothesis Excellence Award emphasize scientific originality, measurable research impact, and contributions that advance academic and societal understanding. Aya EL-Taibany’s scholarly profile demonstrates characteristics that align with these principles, including peer-reviewed publications, citation performance, and involvement in innovative biomedical research activities. Such attributes support consideration for recognition within international research award programs.[2]

Conclusion

Aya EL-Taibany’s academic profile reflects a focused contribution to medicine and regenerative research through publications that have achieved meaningful scholarly visibility. Bibliometric indicators and institutional affiliation provide evidence of sustained scientific engagement and support the relevance of this work within contemporary biomedical research. Recognition through academic excellence programs is consistent with the demonstrated impact and quality of the documented research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Aya EL-Taibany, Author ID 57217169106. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57217169106
  2. International Research Hypothesis. (n.d.). International Research Hypothesis Excellence Award.
    https://researchhypothesis.com/
  3. Mason, C., Dunnill, P. (2008). A brief definition of regenerative medicine. Regenerative Medicine, 3(1), 1–5.
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
  5. Nzou, G., Wicks, R. T., VanOstrand, N. R., Mekky, G. A., Seale, S. A., El-Taibany, A., … Atala, A. (2020). Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood-brain barrier dysfunction.

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Dr Tracey Young-Sharma, Ministry of Health and Medical Service FIji, Fiji

Dr. Tracey Young-Sharma is an accomplished physician specializing in internal medicine and antimicrobial resistance (AMR). She holds a Masters of Medicine from Fiji National University (2019) and has been awarded the ASID GOLD Medal. Currently an AMR consultant for the World Health Organization, Dr. Young-Sharma has held various roles, including Consultant Physician and Registrar at CWM Hospital. She has contributed to multiple studies on antimicrobial resistance and its impact in Fiji, with notable publications in The Lancet and JGAR. Dr. Young-Sharma is also the Chairperson of the Infection Prevention Control Committee at CWMH. 🏥🦠📚🌍

Publication Profile

Scopus

Education

Dr. Tracey Young-Sharma is a highly accomplished medical professional with a strong background in Internal Medicine. She completed her Masters of Medicine in Internal Medicine at Fiji National University in 2019. Prior to that, she earned a Postgraduate Diploma in Internal Medicine in 2016 and a Bachelor’s degree in Medicine and Surgery from the Fiji School of Medicine in 2010. Dr. Young-Sharma has been recognized for her excellence in the field, receiving the prestigious Australian Society of Infectious Disease (ASID) GOLD Medal Award 🏅💉. Her dedication to improving healthcare continues to inspire and impact the medical community. 👩‍⚕️🌟

Experience

Dr. Tracey Young-Sharma is an AMR consultant for the World Health Organisation (WHO) since August 2024 🌍. Previously, she served as a Consultant Physician at CWM Hospital (2022-2024) 🏥 and as a Registrar at the same hospital from 2016 to 2021. Prior to that, she worked as a Registrar in Internal Medicine at Labasa Hospital in 2015 🩺. Dr. Young-Sharma began her career as a Medical Officer at Levuka Hospital and Koro Health Centre (2012-2014) 🏥 and completed her internship at CWM Hospital in 2011. Her extensive experience spans various medical roles, contributing to healthcare development. 👩‍⚕️🌿

Professional Memberships 

Dr. Tracey Young-Sharma is a dedicated healthcare professional with strong affiliations in the medical field. She is an Associate Member of the Internal Medicine Society of Australia and New Zealand and a member of the Internal Medicine Organisation of the Pacific. Additionally, Dr. Young-Sharma is part of the International Women’s Association, the Fiji Medical Association, and the Australasian College of Infection Prevention and Control. In 2022, she served as the Chairperson of the Infection Prevention and Control Committee at CWMH. Her active roles reflect her commitment to advancing healthcare and fostering collaboration in the medical community. 🌍👩‍⚕️💉🩺

Research Focus

Dr. Tracey Young-Sharma’s research primarily focuses on antimicrobial resistance (AMR), particularly in resource-limited settings like Fiji. Her work involves genomic surveillance and epidemiological studies to understand the spread of carbapenem-resistant organisms and other multidrug-resistant pathogens. Dr. Young-Sharma’s studies also emphasize the impact of AMR on healthcare outcomes, including attributable mortality and length of hospital stays. She is also involved in improving healthcare workers’ knowledge and readiness to combat AMR through intervention studies. Her research aims to inform public health strategies and healthcare policies in the context of global AMR challenges. 🦠🔬🌍👩‍🔬💉

Publication Top Notes

Successful management of a multi-species outbreak of carbapenem-resistant organisms in Fiji: a prospective genomics-enhanced investigation and response

Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention study

The epidemiology of enterococci in a tertiary hospital and primary healthcare facilities in Fiji (2019–2022)

The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019–2022

Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji

Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: A prospective cohort study